Vol 4 (May 2021): Gastrointestinal Stromal Tumor

Case Report 
Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases
Philippos Apolinario Costa, Caroline Kamal Abdelmessih Hana, Navin Chakravarthy Balaji, Anthony Frank Skryd, Brianna Nicole Valdes, Ramon O. Minjares, Priscila Barreto-Coelho, Andrea P. Espejo-Freire, Muhammad O. Hakim, Emily Jonczak, Ty Subhawong, Alan Livingstone, Jonathan C. Trent, Gina Z. D'Amato
Gastrointestinal Stromal Tumor  
2021;
4:
1  
(31 May 2021) 
PDF Full Text (2186) Reporting Checklist COI Form Open Access Get Permission